Monday, 18 November 202400:00 | | Keynote Presentation Title to be Confirmed. Noah Malmstadt, Professor, Mork Family Dept. of Chemical Engineering & Materials Science, University of Southern California, United States of America
|
| 00:00 | | Plenary Presentation Title to be Confirmed. Valérie Taly, CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité, France
|
| 00:00 | | Plenary Presentation Title to be Confirmed. Kevin Healy, Jan Fandrianto and Selfia Halim Distinguished Professorship in Engineering, University of California, Berkeley, United States of America
|
| 00:00 | | Plenary Presentation Title to be Confirmed. Abraham Lee, Chancellor’s Professor, Biomedical Engineering & Director, Center for Advanced Design & Manufacturing of Integrated Microfluidics, University of California-Irvine, United States of America
|
| 00:00 | | Plenary Presentation Organ-on-Chip Systems to Probe Immune Cell and Extracellular Vesicle Trafficking Steven C. George, Edward Teller Distinguished Professor and Chair, Department of Biomedical Engineering, University of California-Davis, United States of America
|
| 00:00 | | Plenary Presentation Title to be Confirmed. Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT), United States of America
|
| 00:00 | | Plenary Presentation Title to be Confirmed. David Weitz, Mallinckrodt Professor of Physics and Applied Physics, Director of the Materials Research Science and Engineering Center, Harvard University, United States of America
|
| 00:00 | | Plenary Presentation Title to be Confirmed. Adam Abate, Professor of Bioengineering and Therapeutic Sciences, University of California-San Francisco, United States of America
|
| 00:00 | | Keynote Presentation Title to be Confirmed. Gregory Nordin, Professor, Brigham Young University, United States of America
|
| 00:00 | Research to Commercialization - Perspective on Microfluidic Product Development Leanna Levine, Founder & CEO, ALine, Inc.
This talk will explore at a high level the translation of science and nascent engineering programs into a well-structured product development program to address Reduction to Practice or proof of concept; Human factors engineering – what is it and why it matters; Design Control and Risk Control Roadmap for Development; Design for Manufacture and Assembly; Scale -up progression and manufacturing methods.
| 00:00 | | Conference Chair Title to be Confirmed. Dino Di Carlo, Armond and Elena Hairapetian Chair in Engineering and Medicine, Professor and Vice Chair of Bioengineering, University of California-Los Angeles, United States of America
|
| 00:00 | | Conference Chair Title to be Confirmed. Leanna Levine, Founder & CEO, ALine, Inc., United States of America
|
|
|